RECENT NEWS

Valproate-containing medicines will be dispensed in the manufacturer’s original full pack, following changes in regulations that came into effect on Wednesday, 11 October 2023. The Medicines and Healthcare products Regulatory Agency (MHRA) has published new guidance for dispensers to support this change.

Healthcare Innovation Consortium (HIC) – a leading UK-based digital health and social care agency – is launching a new programme aimed at combatting antimicrobial resistance (AMR) at Global Health 2023.

A partnership between Medicines Discovery Catapult (MDC), the Medical Research Council (MRC) and Innovate UK will deliver scientific breakthroughs with the launch of the UK's first-of-its-kind national total-body positron emission tomography (PET) imaging platform for drug discovery.

Microsure has announced the successful closing of its Series B2 investment round securing € 38 million in development capital. With this funding, Microsure will finalise development of its newest microsurgical robot MUSA-3 for clinical studies followed by FDA clearance in the US and CE-mark in Europe.

A procedure which reduces the size of the stomach by two-thirds to help people living with obesity to lose weight has been deemed safe and effective to be used in the NHS, NICE has said.

A major trial has proved the potential to deliver crucial medical supplies to hospitals via drone – saving time, money and carbon emissions.

Students will be able to apply to new medical school places a year early as the government has announced it will fund 205 additional places for students starting in 2024, accelerating a commitment in the NHS Long Term Workforce Plan published in June.

The government has announced it will invest £30 million in innovative medical technology to help ease pressures on the NHS this winter, which could include the expansion of 3D checks that speed up cancer tests and novel logistics solutions such as the use of drones.

BIOHIT HealthCare is pleased to announce its upcoming webinar titled 'Proactive vs reactive therapeutic drug monitoring in inflammatory bowel disease (IBD)'. The event will take place on the 26th of October at 11 am, and will include a live Q&A with the expert speakers, moderated by The Clinical Services Journal.

Anxiety/stress/depression/other psychiatric illnesses were the most reported reasons for sickness, accounting for over 502,570 full time equivalent days lost and 26.4% of all sickness absence in May 2023. This has increased since April 2023 (25.5%).

A new draft NICE guideline for inherited ovarian cancer recommends that more people should be tested for genes linked to ovarian cancer.

People across England are being encouraged to use the NHS App as an easy way to register their organ donation decision – as more than 7,000 patients actively wait for a transplant.

Secretary of State for Health and Social Care, Steve Barclay, has unveiled measures to tackle aortic dissection, a life-threatening heart condition that kills 2,000 people every year.

The Institute of Biomedical Science (IBMS) recently unveiled its long-term biomedical scientist workforce plan, including a strategy for the UK to develop the biomedical scientist workforce to operate at the highest levels of practice through training, experience and professional qualifications.

New polling from Ipsos and the Health Foundation shows the public wants additional investment in the NHS. Four out of 5 people (80%) support additional funding for the NHS, according to the survey.

Medovate, the Cambridge-based medical device development company, has concluded a distribution agreement with Fannin, giving the Dublin-based company distribution rights for SAFIRA (SAFer Injection for Regional Anaesthesia) across Ireland.

The British Thoracic Society (BTS) has published a Clinical Statement that provides a snapshot of current knowledge and best practice in pulmonary rehabilitation.

London Hearts and the Mindray BeneHeart C1A AED have been selected as the supplier and defibrillator of choice by the Department of Health & Social Care (DHSC) for its new £1 million Community Automated External Defibrillators (AEDs) Fund.

Women could be opting to have unnecessary surgery to avoid breast cancer, after being told they are at high risk from genetic test results. However, these genetic test results do not take family history into account.

Cancer Research UK will award up to £123 million over a seven-year funding commitment to the Beatson Institute. The investment will bolster Scotland as a major global hub for cancer research and help the recruitment of international talent.